Retatrutide is a new pharmaceutical in the fight against obesity. This revolutionary drug, classified as a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By boosting these https://victorlbyr192629.targetblogs.com/36686050/tirzepatide-a-promising-new-treatment-for-obesity